| KERX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the KERX market cap history going back to 3/15/2010:
Also see: KERX Shares Outstanding History and KERX YTD Return |
KERX Market Cap History — Keryx Biopharmaceuticals Capitalization Over Time
As of 10/31/2018 Keryx Biopharmaceuticals has a market cap of 334.65 million. Investors often follow the KERX market cap history to compare the size of the company over time.
This page shows KERX market capitalization trends over time, with 35 market cap datapoints presented, dating back to 3/15/2010.
| KERX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
KERX Historical Market Cap: +9.30% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KERX Stock Price Chart |
| About Keryx Biopharmaceuticals Inc. |
| Keryx Biopharmaceuticals is a commercial stage biopharmaceutical company focused on bringing medicines to people with kidney disease. Co.'s marketed product, Auryxia (ferric citrate) tablets, is an orally available, absorbable, iron-based medicine. Auryxia is used for the control of serum phosphorus levels in patients with chronic kidney disease (CKD), on dialysis. Auryxia is also for the treatment of iron deficiency anemia in adults with CKD, not on dialysis. Ferric citrate is also approved in Japan under the trade name Riona and marketed by Co.'s Japanese partner, Japan Tobacco, Inc. and its subsidiary, Torii Pharmaceutical Co., Ltd., and approved in Europe as Fexeric. We show 35 historical shares outstanding datapoints in our KERX shares outstanding history coverage, used to compute KERX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing KERX market cap history over the course of time is important for investors interested in comparing KERX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of KERX versus a peer is one thing; comparing KERX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like KERX can fluctuate over the course of history. With this page we aim to empower investors researching KERX by allowing them to research the KERX market cap history. |
| KERX Current Stock Quote |
Quotes delayed 20 minutes  Free KERX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| KERX Share Performance |
| Market Cap Peers |
| Keryx Biopharmaceuticals (KERX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
KIDS Market Cap History KIN Market Cap History KLDO Market Cap History KLRS Market Cap History KMPH Market Cap History KND Market Cap History KNTE Market Cap History KOD Market Cap History KOOL Market Cap History KPRX Market Cap History More Healthcare companies » |
KERX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
